Potent Phagocytic Activity Discriminates Metastatic and Primary Human Malignant Melanomas: A Key Role of Ezrin

Laboratory Investigation - Tập 83 - Trang 1555-1567 - 2003
Luana Lugini1, Francesco Lozupone1, Paola Matarrese2, Cristina Funaro1, Francesca Luciani1, Walter Malorni2, Licia Rivoltini3, Chiara Castelli3, Antonella Tinari2, Adriano Piris3, Giorgio Parmiani3, Stefano Fais1
1Laboratory of Immunology, Istituto Superiore di Sanità, Rome, Italy
2Laboratory of Ultrastructures, Istituto Superiore di Sanità, Rome, Italy
3Unit of Immunotherapy of Human Tumors, Istituto Nazionale dei Tumori, Milan, Italy

Tài liệu tham khảo

Andreola, 2002, Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles, J Exp Med, 195, 1303, 10.1084/jem.20011624 Banerjee, 2000, Morphological and immunophenotypic variations in malignant melanoma, Histopathology, 36, 387, 10.1046/j.1365-2559.2000.00894.x Bretscher, 1997, Ezrin: A protein requiring conformational activation to link microfilaments to the plasma membrane in the assembly of cell surface structures, J Cell Sci, 110, 3011, 10.1242/jcs.110.24.3011 Brouwer, 1984, Serum-dependent “cannibalism” and autodestruction in cultures of human small cell carcinoma of the lung, Cancer Res, 44, 2947 Clark, 2000, Genomic analysis of metastasis reveals an essential role for RhoC, Nature, 406, 532, 10.1038/35020106 Coopman, 1998, Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity, Clin Cancer Res, 4, 507 Defacque, 2000, Involvement of ezrin/moesin in de novo actin assembly on phagosomal membranes, EMBO J, 19, 199, 10.1093/emboj/19.2.199 Dell'Angelica, 2000, Lysosome-related organelles, FASEB J, 14, 1265 DeSimone, 1980, Phagocytic tumor cell activity in oat cell carcinoma of the lung, Human Pathol, 11, 535 Fiorentini, 2001, Activation of Rho-GTPases by cytotoxic necrotizing factor 1 induces macropinocytosis and scavenging activity in epithelial cells, Mol Biol Cell, 12, 2061, 10.1091/mbc.12.7.2061 Gautreau, 2002, ERM proteins and NF2 tumor suppressor: The Yin and Yang of cortical actin organization and cell growth signaling, Curr Opin Cell Biol, 1, 104, 10.1016/S0955-0674(01)00300-3 Hu, 2000, Deficient in vitroin vivo phagocytosis of apoptotic T cells by resident murine alveolar macrophages, J Immunol, 165, 2124, 10.4049/jimmunol.165.4.2124 Jonjic, 1992, Regulated expression of vascular cell adhesion molecule-1 in human malignant melanoma, Am J Pathol, 141, 1323 Kaminski, 1985, A rapid spectrophotometric method for assessing macrophage phagocytic activity, Immunol Lett, 10, 329, 10.1016/0165-2478(85)90127-0 Koga, 1992, Generation of superoxide during the enzymatic action of tyrosinase, Arch Biochem Biophys, 292, 570, 10.1016/0003-9861(92)90032-R Kuroda, 1999, Prostatic signet-ring cell carcinoma: Case report and literature review, Pathol Int, 49, 457, 10.1046/j.1440-1827.1999.00876.x Le Poole, 1993, Phagocytosis by normal human melanocytes in vitro, Exp Cell Res, 205, 388, 10.1006/excr.1993.1102 Luciani, 2002, P-glycoprotein-actin association through ERM family proteins: A role in P-glycoprotein function in human cells of lymphoid origin, Blood, 99, 641, 10.1182/blood.V99.2.641 Lupetti, 1996, Interaction with fibronectin regulates cytokine gene expression in human melanoma cells, Int J Cancer, 66, 110, 10.1002/(SICI)1097-0215(19960328)66:1<110::AID-IJC19>3.0.CO;2-H Makitie, 2001, Ezrin as a prognostic indicator and its relationship to tumor characteristics in uveal malignant melanoma, Invest Ophthalmol Vis Sci, 42, 2442 Marin-Padilla, 1977, Erythrophagocytosis by epithelial cells of breast carcinoma, Cancer, 39, 1085, 10.1002/1097-0142(197703)39:3<1085::AID-CNCR2820390312>3.0.CO;2-U Montcourrier, 1994, Characterization of very acidic phagosomes in breast cancer cells and their association with invasion, J Cell Sci, 107, 2381, 10.1242/jcs.107.9.2381 Mortarini, 1991, Heterogeneity for integrin expression and cytokine-mediated VLA modulation can influence the adhesion of human melanoma cells to extracellular matrix proteins, Int J Cancer, 47, 551, 10.1002/ijc.2910470413 Mortarini, 1992, Role of the alpha 5 beta 1 integrin receptor in the proliferative response of quiescent human melanoma cells to fibronectin, Cancer Res, 52, 4499 Ohtani, 2002, Ezrin, a membrane-cytoskeletal linking protein, is highly expressed in atypical endometrial hyperplasia and uterine endometrioid adenocarcinoma, Cancer Lett, 179, 79, 10.1016/S0304-3835(01)00857-6 Ohtani, 1999, Ezrin, a membrane-cytoskeletal linking protein, is involved in the process of invasion of endometrial cancer cells, Cancer Lett, 147, 31, 10.1016/S0304-3835(99)00272-4 Parlato, 2000, CD95 (APO-1/Fas) linkage to the actin cytoskeleton through Ezrin in human T lymphocytes: A novel regulatory mechanism of the CD95 apoptotic pathway, EMBO J, 19, 5123, 10.1093/emboj/19.19.5123 Parlato, 2001, Expression of CCR-7, MIP-3beta, and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: Importance for the rapid acquisition of potent migratory and functional activities, Blood, 98, 3022, 10.1182/blood.V98.10.3022 Pietra, 2001, Phases of apoptosis of melanoma cells, but not of normal melanocytes, differently affect maturation of myeloid dendritic cells, Cancer Res, 61, 8218 Ramoni, 2002, Differential expression and distribution of ezrin, radixin and moesin in human natural killer cells, Eur J Immunol, 32, 3059, 10.1002/1521-4141(200211)32:11<3059::AID-IMMU3059>3.0.CO;2-3 Rodolfo, 1988, Tumorigenicity and dissemination of primary and metastatic human melanomas implanted into different sites in athymic nude mice, Invasion Metastasis, 8, 317 Steinhaus, 1891, Ueber carcinom-einschlüsse, Virchows Arch, 126, 533, 10.1007/BF01937613 Tauton, 2001, Actin filament nucleation by endosomes, lysosomes and secretory vesicles, Curr Opin Cell Biol, 13, 85, 10.1016/S0955-0674(00)00178-2 Tsang, 1992, Signet-ring cell melanoma mimicking adenocarcinoma, Acta Cytol, 37, 559 Yonemura, 2002, Rho-dependent and -independent activation mechanisms of ezrin/radixin/moesin proteins: An essential role for polyphosphoinositides in vivo, J Cell Sci, 115, 2569, 10.1242/jcs.115.12.2569